当前位置: X-MOL 学术Lancet Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Lung cancer screening and its continuous risk assessment
The Lancet Oncology ( IF 41.6 ) Pub Date : 2017-10-17 , DOI: 10.1016/s1470-2045(17)30730-1
Harry J de Koning

First page of articleAfter decades of relatively unsuccessful attempts to improve survival for patients with lung cancer, CT screening has changed the scene. After publication of the results from a pioneering non-randomised pilot study,1 one large-scale randomised controlled trial in the USA and seven European randomised controlled trials were designed to investigate whether earlier detection of lung cancer—made possible primarily by following up after detection of a high quantity of CT-visible pulmonary nodules in high-risk people, which had not yet given rise to complaints—could be followed by earlier, more effective treatment.

中文翻译:

肺癌筛查及其持续风险评估

文章首页经过数十年相对不成功的尝试来提高肺癌患者的生存率,CT筛查改变了现场。从开拓非随机试验研究的结果公布后,1一体的大型随机对照试验,在美国和欧洲七随机主要通过检测后随访对照试验旨在探讨肺癌的早期发现是否癌症成为可能在尚未引起投诉的高危人群中,如果发现大量CT可见的肺结节,可以采取更早期,更有效的治疗方法。
更新日期:2017-11-10
down
wechat
bug